Plasma anti‐BIRC5 IgG may be a useful marker for evaluating the prognosis of nonsmall cell lung cancer

A recent study demonstrated that circulating levels of IgG antibodies against linear peptide antigens derived from baculoviral IAP repeat‐containing protein 5 isoform 2 (BIRC5) and myc proto‐oncogene protein (MYC) were significantly increased in nonsmall cell lung cancer (NSCLC). This study was unde...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Huan, Zhang, Xuan, Han, Zhifeng, Wang, Zhenqi, Wang, Yao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929924/
https://www.ncbi.nlm.nih.gov/pubmed/29744296
http://dx.doi.org/10.1002/2211-5463.12417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929924/
https://www.ncbi.nlm.nih.gov/pubmed/29744296
http://dx.doi.org/10.1002/2211-5463.12417

Ejemplares similares